仁度生物 (688193)
Shanghai Rendu Biotechnology Co., Ltd.
K-Line Chart
No K-line data available
Company NameShanghai Rendu Biotechnology Co., Ltd.
Listing Date2022-03-30
Issue Price72.65RMB
Registered Capital4006.98710k RMB
Legal RepresentativeJulian Ju
Registered AddressBuilding 15-B, No. 528 Ruiqing Road, East Zone, Zhangjiang Hi-Tech Park, Shanghai
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of integrated molecular diagnostic reagent and equipment products based on this technology platform, focusing on providing solutions for precise diagnosis, effective prevention and control, and personalized treatment of pathogens in the fields of reproduction, respiration, digestion, hematology, food, and environmental safety.
Company ProfileSince its establishment, Shanghai Rendu Biotechnology Co., Ltd. has actively committed to the national strategy of 'Healthy China'. It is one of the earliest life science enterprises in China focusing on RNA molecular diagnostic technology and products, dedicated to developing innovative diagnostic technologies and products that address unmet clinical needs.
The company and its subsidiaries have obtained approval from the National Medical Products Administration or filed with the drug regulatory authorities for a total of 20 medical device products, including 13 Class III medical device registration products and 7 Class I medical device filing products.
Leveraging its product and technological advantages, the company's products cover over 500 medical institutions (including 275 Grade A Tertiary hospitals) across 31 provinces, municipalities, and autonomous regions in China. These include many renowned hospitals such as Peking Union Medical College Hospital, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, The First Affiliated Hospital of Sun Yat-sen University, Xijing Hospital of Air Force Medical University, Peking University Third Hospital, The First Affiliated Hospital of Zhejiang University School of Medicine, and Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Motor Corporation Limited
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established with Beijing Capital Venture Group as the main sponsor....
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5,000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3,200 | 6.5 |
| 3 | Hillhouse Capital Management | Private Equity Fund | 2,800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2,500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2,000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1,800 | 3.7 |
| 7 | CITIC Securities Co., Ltd. | Securities Company | 1,500 | 3.1 |
| 8 | Guotai Junan Securities Co., Ltd. | Securities Company | 1,200 | 2.4 |
| 9 | China Merchants Bank Co., Ltd. | Bank | 1,000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information